-
CDK Inhibitors Boost Neuroblastoma Differentiation, Retinoic Acid Sensitivity
03 Aug 2025 03:22 GMT
… the therapeutic interventions. Differentiated neuroblastoma cells displayed decreased clonogenic … with differentiation pathways in neuroblastoma, the work underscores … treatment.
Subject of Research: Neuroblastoma, CDK inhibition, cellular differentiation …
-
Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100%
06 Aug 2025 16:38 GMT
… relapsed or refractory high-risk neuroblastoma.
The drug won accelerated FDA … relapsed or refractory high-risk neuroblastoma in the bone or bone … system/leptomeningeal metastasis from neuroblastoma. Shortly after that setback, the …
-
Why Y-mAbs Therapeutics Is Skyrocketing Today: A Deep Dive into the Big News
06 Aug 2025 17:03 GMT
… relapsed or refractory high-risk neuroblastoma—a rare and aggressive form …
-
Onvansertib Shows Promising Early Efficacy in First-Line KRAS-Mutated mCRC
06 Aug 2025 11:23 GMT
… Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation. ClinicalTrials.gov …
-
Erectile Dysfunction Devices Market to Surpass 6.32 Billion USD by 2032 at 9.5% CAGR Growth
06 Aug 2025 10:07 GMT
… ;pharmaceutical-waste-management-market-6548
Neuroblastoma Market: https://www … .marketresearchfuture.com/reports/neuroblastoma-market-6555
Periodontal Therapeutics Market …
-
Teen with rare cancer pleads for financial aid
06 Aug 2025 05:21 GMT
… battling stage four Thoracoabdominal Paraspinal Neuroblastoma is urgently in need of …
-
Nurul Syahira Needs Over RM500,000 For Cancer Treatment
06 Aug 2025 04:41 GMT
… battling stage four Thoracoabdominal Paraspinal Neuroblastoma is urgently in need of …
-
7 fantastic shots of Jermain Defoe enjoying a kickabout as he catches up with Bradley Lowery's mam
06 Aug 2025 04:41 GMT
… with stage 4 high risk neuroblastoma in 2017, Jermain has continued …
-
Jermain Defoe hands over £70,000 cheque to Bradley Lowery Foundation for holiday home
06 Aug 2025 02:45 GMT
… from stage 4 high risk Neuroblastoma in 2017, Jermain has continued …
-
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
05 Aug 2025 12:30 GMT
… relapsed or refractory high-risk neuroblastoma – a rare and aggressive … relapsed or refractory high-risk neuroblastoma in the bone or … on the lives of more neuroblastoma patients and their families.” … or refractory high-risk neuroblastoma in the bone or …